144 related articles for article (PubMed ID: 1312127)
1. Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge.
Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
J Gen Virol; 1992 Mar; 73 ( Pt 3)():719-22. PubMed ID: 1312127
[TBL] [Abstract][Full Text] [Related]
2. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
[TBL] [Abstract][Full Text] [Related]
3. Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge.
Ghiasi H; Kaiwar R; Nesburn AB; Slanina S; Wechsler SL
Virology; 1992 Jun; 188(2):469-76. PubMed ID: 1585630
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L.
Ghiasi H; Kaiwar R; Slanina S; Nesburn AB; Wechsler SL
Arch Virol; 1994; 138(3-4):199-212. PubMed ID: 7998829
[TBL] [Abstract][Full Text] [Related]
5. Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells.
Ghiasi H; Nesburn AB; Wechsler SL
Virology; 1991 Nov; 185(1):187-94. PubMed ID: 1656584
[TBL] [Abstract][Full Text] [Related]
6. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Chan WL; Lukig ML; Liew FY
J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
[TBL] [Abstract][Full Text] [Related]
7. Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1.
Browne H; Baxter V; Minson T
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2813-7. PubMed ID: 8277292
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
9. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
Martin S; Rouse BT
J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
[TBL] [Abstract][Full Text] [Related]
10. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
Ghiasi H; Kaiwar R; Nesburn AB; Slanina S; Wechsler SL
J Virol; 1994 Apr; 68(4):2118-26. PubMed ID: 8138996
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
12. Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge.
Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
Virology; 1992 Sep; 190(1):233-9. PubMed ID: 1529531
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
Martin S; Cantin E; Rouse BT
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
[TBL] [Abstract][Full Text] [Related]
14. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
15. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
[TBL] [Abstract][Full Text] [Related]
16. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.
Krishna S; Blacklaws BA; Overton HA; Bishop DH; Nash AA
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1805-14. PubMed ID: 2544667
[TBL] [Abstract][Full Text] [Related]
17. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants.
Blacklaws BA; Krishna S; Minson AC; Nash AA
Virology; 1990 Aug; 177(2):727-36. PubMed ID: 2164732
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein.
Ghiasi H; Nesburn AB; Wechsler SL
Vaccine; 1996 Feb; 14(2):107-12. PubMed ID: 8852405
[TBL] [Abstract][Full Text] [Related]
20. Suppression of delayed type hypersensitivity to herpes simplex virus type 1 following immunization with anti-idiotypic antibody: an example of split tolerance.
Lathey JL; Martin S; Rouse BT
J Gen Virol; 1987 Apr; 68 ( Pt 4)():1093-102. PubMed ID: 3033128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
